Enterobacteriaceae Infection Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063586
  • May 2021
  • Pharmaceuticals
  • 114 Pages
The global Enterobacteriaceae Infection Drug market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Enterobacteriaceae Infection Drug market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Enterobacteriaceae Infection Drug market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Enterobacteriaceae Infection Drug market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Genentech, Inc., Allergan, Novartis AG, Pfizer Inc., Nymox Pharmaceutical Corporation, Sequoia Sciences, Inc., Phico Therapeutics Ltd., Melinta Therapeutics, Inc., Spero Therapeutics, Cipla USA, Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Enterobacteriaceae Infection Drug market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Enterobacteriaceae Infection Drug market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Enterobacteriaceae Infection Drug market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Enterobacteriaceae Infection Drug market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Enterobacteriaceae Infection Drug Market:
The Enterobacteriaceae Infection Drug market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Genentech, Inc., Allergan, Novartis AG, Pfizer Inc., Nymox Pharmaceutical Corporation, Sequoia Sciences, Inc., Phico Therapeutics Ltd., Melinta Therapeutics, Inc., Spero Therapeutics, Cipla USA, Inc.

Enterobacteriaceae Infection Drug Market Segment Analysis:
By Type
Beta-Lactams Drugs
Carbapenems Drugs
Fluoroquinolones Drugs
Others
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Geographic Coverage for Enterobacteriaceae Infection Drug Market:
The market research report on global Enterobacteriaceae Infection Drug market offers complete analysis across various regions across the world. The Enterobacteriaceae Infection Drug market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Enterobacteriaceae Infection Drug market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Enterobacteriaceae Infection Drug Market Value and Forecast
  • US
  • Canada
Europe Enterobacteriaceae Infection Drug Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Enterobacteriaceae Infection Drug Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Enterobacteriaceae Infection Drug Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Enterobacteriaceae Infection Drug Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Enterobacteriaceae Infection Drug market report:
  • The report provides key trends of the global Enterobacteriaceae Infection Drug market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Enterobacteriaceae Infection Drug industry
  • The report covers all the recent developments of the Enterobacteriaceae Infection Drug market and helps to provide current industry updates
  • The report covers a detailed look over the global Enterobacteriaceae Infection Drug Industry and provides with significant actionable insights
  • The Enterobacteriaceae Infection Drug market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Enterobacteriaceae Infection Drug market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Enterobacteriaceae Infection Drug market
  • Comprehensive analysis of the Enterobacteriaceae Infection Drug market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Enterobacteriaceae Infection Drug market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Enterobacteriaceae Infection Drug market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Enterobacteriaceae Infection Drug market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Enterobacteriaceae Infection Drug market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Enterobacteriaceae Infection Drug market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Genentech, Inc.
  • Allergan
  • Novartis AG
  • Pfizer Inc.
  • Nymox Pharmaceutical Corporation
  • Sequoia Sciences, Inc.
  • Phico Therapeutics Ltd.
  • Melinta Therapeutics, Inc.
  • Spero Therapeutics
  • Cipla USA, Inc.
  • Beta-Lactams Drugs
  • Carbapenems Drugs
  • Fluoroquinolones Drugs
  • Others
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Enterobacteriaceae Infection Drug Market Snapshot
          2.1.1. Global Enterobacteriaceae Infection Drug Market By Type,2019
               2.1.1.1.Beta-Lactams Drugs
               2.1.1.2.Carbapenems Drugs
               2.1.1.3.Fluoroquinolones Drugs
               2.1.1.4.Others
          2.1.2. Global Enterobacteriaceae Infection Drug Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Online Pharmacies
          2.1.3. Global Enterobacteriaceae Infection Drug Market By End-use,2019
          2.1.4. Global Enterobacteriaceae Infection Drug Market By Geography,2019

3. Global Enterobacteriaceae Infection Drug Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Enterobacteriaceae Infection Drug Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Enterobacteriaceae Infection Drug Market Size (US$), By Type, 2018 – 2028

5. Global Enterobacteriaceae Infection Drug Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Enterobacteriaceae Infection Drug Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Enterobacteriaceae Infection Drug Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Enterobacteriaceae Infection Drug Market Size (US$), By End-use, 2018 – 2028

7. Global Enterobacteriaceae Infection Drug Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Enterobacteriaceae Infection Drug Market Analysis, 2018 – 2028 
          7.2.1. North America Enterobacteriaceae Infection Drug Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Enterobacteriaceae Infection Drug Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Enterobacteriaceae Infection Drug Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Enterobacteriaceae Infection Drug Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Enterobacteriaceae Infection Drug Market Analysis, 2018 – 2028 
          7.3.1.  Europe Enterobacteriaceae Infection Drug Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Enterobacteriaceae Infection Drug Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Enterobacteriaceae Infection Drug Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Enterobacteriaceae Infection Drug Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Enterobacteriaceae Infection Drug Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Enterobacteriaceae Infection Drug Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Enterobacteriaceae Infection Drug Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Enterobacteriaceae Infection Drug Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Enterobacteriaceae Infection Drug Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Enterobacteriaceae Infection Drug Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Enterobacteriaceae Infection Drug Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Enterobacteriaceae Infection Drug Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Enterobacteriaceae Infection Drug Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Enterobacteriaceae Infection Drug Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Enterobacteriaceae Infection Drug Market Analysis, 2018 – 2028 
          7.6.1.  MEA Enterobacteriaceae Infection Drug Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Enterobacteriaceae Infection Drug Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Enterobacteriaceae Infection Drug Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Enterobacteriaceae Infection Drug Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Enterobacteriaceae Infection Drug Providers
        8.4.1 Genentech, Inc.
                8.4.1.1 Business Description
                8.4.1.2 Genentech, Inc. Geographic Operations
                8.4.1.3 Genentech, Inc. Financial Information
                8.4.1.4 Genentech, Inc. Product Positions/Portfolio
                8.4.1.5 Genentech, Inc. Key Developments
        8.4.2 Allergan
                8.4.2.1 Business Description
                8.4.2.2 Allergan Geographic Operations
                8.4.2.3 Allergan Financial Information
                8.4.2.4 Allergan Product Positions/Portfolio
                8.4.2.5 Allergan Key Developments
        8.4.3 Novartis AG
                8.4.3.1 Business Description
                8.4.3.2 Novartis AG Geographic Operations
                8.4.3.3 Novartis AG Financial Information
                8.4.3.4 Novartis AG Product Positions/Portfolio
                8.4.3.5 Novartis AG Key Developments
        8.4.4 Pfizer Inc.
                8.4.4.1 Business Description
                8.4.4.2 Pfizer Inc. Geographic Operations
                8.4.4.3 Pfizer Inc. Financial Information
                8.4.4.4 Pfizer Inc. Product Positions/Portfolio
                8.4.4.5 Pfizer Inc. Key Developments
        8.4.5 Nymox Pharmaceutical Corporation
                8.4.5.1 Business Description
                8.4.5.2 Nymox Pharmaceutical Corporation Geographic Operations
                8.4.5.3 Nymox Pharmaceutical Corporation Financial Information
                8.4.5.4 Nymox Pharmaceutical Corporation Product Positions/Portfolio
                8.4.5.5 Nymox Pharmaceutical Corporation Key Developments
        8.4.6 Sequoia Sciences, Inc.
                8.4.6.1 Business Description
                8.4.6.2 Sequoia Sciences, Inc. Geographic Operations
                8.4.6.3 Sequoia Sciences, Inc. Financial Information
                8.4.6.4 Sequoia Sciences, Inc. Product Positions/Portfolio
                8.4.6.5 Sequoia Sciences, Inc. Key Developments
        8.4.7 Phico Therapeutics Ltd.
                8.4.7.1 Business Description
                8.4.7.2 Phico Therapeutics Ltd. Geographic Operations
                8.4.7.3 Phico Therapeutics Ltd. Financial Information
                8.4.7.4 Phico Therapeutics Ltd. Product Positions/Portfolio
                8.4.7.5 Phico Therapeutics Ltd. Key Developments
        8.4.8 Melinta Therapeutics, Inc.
                8.4.8.1 Business Description
                8.4.8.2 Melinta Therapeutics, Inc. Geographic Operations
                8.4.8.3 Melinta Therapeutics, Inc. Financial Information
                8.4.8.4 Melinta Therapeutics, Inc. Product Positions/Portfolio
                8.4.8.5 Melinta Therapeutics, Inc. Key Developments
        8.4.9 Spero Therapeutics
                8.4.9.1 Business Description
                8.4.9.2 Spero Therapeutics Geographic Operations
                8.4.9.3 Spero Therapeutics Financial Information
                8.4.9.4 Spero Therapeutics Product Positions/Portfolio
                8.4.9.5 Spero Therapeutics Key Developments
        8.4.10 Cipla USA, Inc.
                8.4.10.1 Business Description
                8.4.10.2 Cipla USA, Inc. Geographic Operations
                8.4.10.3 Cipla USA, Inc. Financial Information
                8.4.10.4 Cipla USA, Inc. Product Positions/Portfolio
                8.4.10.5 Cipla USA, Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Enterobacteriaceae Infection Drug Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Enterobacteriaceae Infection Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Enterobacteriaceae Infection Drug Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Enterobacteriaceae Infection Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Enterobacteriaceae Infection Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Enterobacteriaceae Infection Drug Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Enterobacteriaceae Infection Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Enterobacteriaceae Infection Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Enterobacteriaceae Infection Drug Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Enterobacteriaceae Infection Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Enterobacteriaceae Infection Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Enterobacteriaceae Infection Drug Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Enterobacteriaceae Infection Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Enterobacteriaceae Infection Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Enterobacteriaceae Infection Drug Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Enterobacteriaceae Infection Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Enterobacteriaceae Infection Drug: Market Segmentation 
FIG. 2 Global Enterobacteriaceae Infection Drug Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Enterobacteriaceae Infection Drug Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Enterobacteriaceae Infection Drug Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Enterobacteriaceae Infection Drug Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Enterobacteriaceae Infection Drug Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Enterobacteriaceae Infection Drug Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Enterobacteriaceae Infection Drug Providers, 2019
FIG. 11 Global Enterobacteriaceae Infection Drug Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Enterobacteriaceae Infection Drug Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Enterobacteriaceae Infection Drug Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Enterobacteriaceae Infection Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Enterobacteriaceae Infection Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Enterobacteriaceae Infection Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Enterobacteriaceae Infection Drug Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Enterobacteriaceae Infection Drug Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Enterobacteriaceae Infection Drug market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Enterobacteriaceae Infection Drug Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Enterobacteriaceae Infection Drug Market Value, By Segment1, 2018 – 2028
TABLE  North America Enterobacteriaceae Infection Drug Market Value, By Segment2, 2018 – 2028
TABLE  North America Enterobacteriaceae Infection Drug Market Value, By Country, 2018 – 2028
TABLE  Europe Enterobacteriaceae Infection Drug Market Value, By Segment1, 2018 – 2028
TABLE  Europe Enterobacteriaceae Infection Drug Market Value, By Segment2, 2018 – 2028
TABLE  Europe Enterobacteriaceae Infection Drug Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Enterobacteriaceae Infection Drug Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Enterobacteriaceae Infection Drug Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Enterobacteriaceae Infection Drug Market Value, By Country, 2018 – 2028
TABLE  Latin America Enterobacteriaceae Infection Drug Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Enterobacteriaceae Infection Drug Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Enterobacteriaceae Infection Drug Market Value, By Country, 2018 – 2028
TABLE  MEA Enterobacteriaceae Infection Drug Market Value, By Segment1, 2018 – 2028
TABLE  MEA Enterobacteriaceae Infection Drug Market Value, By Segment2, 2018 – 2028
TABLE  MEA Enterobacteriaceae Infection Drug Market Value, By Country, 2018 – 2028
TABLE  Genentech, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Allergan: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Nymox Pharmaceutical Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sequoia Sciences, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Phico Therapeutics Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Melinta Therapeutics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Spero Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cipla USA, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Enterobacteriaceae Infection Drug Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Enterobacteriaceae Infection Drug Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Enterobacteriaceae Infection Drug Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Enterobacteriaceae Infection Drug Market, By Geography, 2019 (US$ Mn)
FIG.  Global Enterobacteriaceae Infection Drug Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Enterobacteriaceae Infection Drug Providers, 2016
FIG.  Global Enterobacteriaceae Infection Drug Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Carbapenems Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Fluoroquinolones Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Enterobacteriaceae Infection Drug Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Enterobacteriaceae Infection Drug Market Value, 2018 – 2028, (US$ Mn)